Orion Pharma

Orion Pharma Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being. Welcome to Orion Pharma page!

On this page, we share information related to Orion Pharma's activities and building well-being. We hope all visitors to the page will behave kindly and respectfully, and honor others' opinions. Please follow the common rules of the page. Inappropriate, offensive, or derogatory messages do not belong in the community spirit, and we reserve the right to remove such comments without warning. Additio

nally, posts that are unrelated to the topic at hand will be removed. Such messages may include comments made for advertising purposes. As a pharmaceutical company, our communication is guided by laws and regulations related to the pharmaceutical industry, as well as ethical guidelines for pharmaceutical marketing. We cannot provide individual treatment instructions or respond to product inquiries on our social media pages. Instead, we ask you to contact your doctor or pharmacy staff for these matters. We cannot give instructions on the use of prescription drugs or provide advice related to your medication. On this page, we also cannot market prescription products from Orion Pharma or other companies to consumers, so we must remove comments that mention the names of medicinal products. We hope for your understanding in this matter. We reserve the right to moderate discussions. Commenting on posts is possible, but starting new discussion threads is not. We reserve the right to remove comments without warning if:

- They relate to prescription drug products. Marketing prescription drugs to consumers is prohibited by Finnish law. Therefore, we cannot publish the names of products on our pages.
- Comments contain individual treatment instructions or recommendations for the use of medicines, or they relate to the treatment of diseases or the use of medicinal products. We cannot provide individual treatment instructions or recommendations on our page. If you need advice on treating a disease or using medicinal products, please contact your doctor or pharmacy.
- We reserve the right to remove comments at our discretion in cases other than those mentioned above. Adverse Drug Reactions

If you want to report a possible adverse reaction to an Orion Pharma medicinal product, you can make an adverse reaction report to the email address: drugsafety@orionpharma.com, or by calling the number: 010 426 2928. The format of the report is free. For drug safety reasons, Orion Pharma may contact you for additional information. Disclaimer

Orion Corporation is not responsible for the comments made by writers on our wall or for any direct or indirect damages caused by conclusions or actions based on them. There may be links on Orion Corporation's wall to pages maintained by external parties. Orion Corporation is not responsible for the content of pages maintained or published by external parties. Thank you for being part of building Orion Pharma's page and for following our common rules. The page administrator is Orion Corporation.

14/04/2026

Pharmacy degree opens doors across pharma. 🔬

A pharmaceutical company can be a versatile and engaging place to build a career with a pharmacy background. Science, manufacturing, quality, and real-world patient needs all come together – and there’s always something new to learn.

11/04/2026

Parkinson’s isn’t only about movement.

On World Parkinson’s Day, we want to recognise the full experience of living with Parkinson’s. While the condition is widely known for physical symptoms, anxiety and depression can also be part of Parkinson’s itself for many people – not simply a reaction to a diagnosis.

Emotional well-being matters. Truly supporting people with Parkinson’s means seeing mind and body together. 💙

09/04/2026

What can a career in pharma offer a pharmacist? 💊

More than you might expect.

We asked two of our pharmacists what keeps their work meaningful every day. Watch the video to hear their story.

07/04/2026

Did you know the pharmaceutical industry offers a wide range of career paths for pharmacy-trained professionals? 💊

At Orion Pharma, the same education can lead you to public affairs, international business, tablet manufacturing or medical affairs – and each path looks completely different.

We asked four Orionees to share their stories. Find the link in the comments 👇

31/03/2026

Orion Pharma’s subsidiary Fermion operates two API manufacturing sites in Finland – and together they play an important role in European medicine supply.

🏭 In Hanko, active pharmaceutical ingredients are produced in large volumes to meet global demand.

🌍 In Oulu, production focuses on smaller, more specialised batches.

Fermion’s work is a practical reminder that European pharmaceutical manufacturing is an everyday reality – and that patients in Europe and beyond already benefit from it.

Patients are at the heart of everything we do. 💙 Across our focus areas, Orion Pharma’s work is guided by a single commi...
27/03/2026

Patients are at the heart of everything we do. 💙 Across our focus areas, Orion Pharma’s work is guided by a single commitment: to build well-being with Nordic excellence in innovation and healthcare.

We’re proud to say that since 2019, around 200,000 patients with prostate cancer have been treated with the medicine invented by Orion Pharma.

In 2025, our medicines reached people around the world, including:

• 250,000+ people living with Parkinson’s disease,
• over 1.5 million asthma and COPD patients using our inhalers, &
• 500,000+ women going through menopause with HRT.

24/03/2026

Reliable access to medicines starts long before a tablet reaches a patient. 💊

The COVID-19 pandemic demonstrated how vulnerable global supply chains can become when critical production is concentrated outside Europe.

Fermion, Orion Pharma’s subsidiary specialising in active pharmaceutical ingredient manufacturing, operates two production sites in Finland. One of them is located in Oulu – the world’s northernmost API facility – where several ingredients on the European critical medicines list are produced.

As discussions around the EU’s Critical Medicines Act continue, Fermion's work is a reminder that European manufacturing resilience isn't just an objective – it's an everyday reality that patients are already benefiting from.

23/03/2026

“Without trust, there can be no peace.” 🌿

As in peacebuilding, trust is essential to our work as a pharmaceutical company. Patients and healthcare professionals around the world rely on us to provide safe, effective, and dependable medicines and self‑care products.

That trust guides everything we do.

We ensure the quality and efficacy of our products at all stages of their life cycles and remain committed to supporting resilient healthcare systems and maintaining a secure supply of medicines – in all circumstances.

is part of Orion Pharma's collaboration with CMI - Martti Ahtisaari Peace Foundation. Learn more ➡️ https://cmi.fi/about-us/prescriptions-for-peace/

Orion Pharma’s innovative pharmaceutical R&D focuses on oncology and pain, driven by a clear goal: to improve the qualit...
20/03/2026

Orion Pharma’s innovative pharmaceutical R&D focuses on oncology and pain, driven by a clear goal: to improve the quality of life of patients and address unmet medical needs. 🔬

In 2025, we invested more than €210 million in our research and development and opened our new Biologics Research & Development Centre in Cambridge, UK.

The Cambridge centre strengthens our scientific capabilities and supports our innovation driven growth strategy by advancing next generation biological therapies. Located in Europe’s leading biomedical hub, the new site enables collaboration with world-class experts to develop future treatments for patients worldwide. 🌍

Much of Europe’s supply of essential medicines depends on active pharmaceutical ingredient (API) manufacturers outside t...
19/03/2026

Much of Europe’s supply of essential medicines depends on active pharmaceutical ingredient (API) manufacturers outside the EU, leaving supply chains vulnerable. 🌍

Orion Pharma’s subsidiary Fermion shows what stronger European manufacturing resilience can look like in practice. With two API production sites in Finland, Fermion manufactures around thirty active pharmaceutical ingredients, making it one of the leading API producers in the Nordics and a significant global supplier of certain products.

“Thanks to our expertise across research, development and operations, we can keep improving the way we manufacture APIs. Small changes in the process can help us increase production volumes as demand grows”, says Kim Nylund, SVP, Fermion.

One success story is the prostate cancer medicine invented by Orion Pharma, which has already helped around 200,000 patients worldwide. The entire medicine is produced in Finland – the active ingredient by Fermion in Hanko and the finished tablets in Espoo.

Read the full story, link in the comments 👇

Building health is building peace. 🌿That's why we're proud to partner with CMI – Martti Ahtisaari Peace Foundation.Toget...
18/03/2026

Building health is building peace. 🌿

That's why we're proud to partner with CMI – Martti Ahtisaari Peace Foundation.

Together, we're launching Prescriptions for Peace – a video series where CMI's peace mediation experts share what sustainable peace requires.

We believe that well-being isn't just personal. It's about how societies hold together, especially in times of uncertainty.

Read more about our partnership and watch the Prescriptions for Peace videos! 👇

None of our work would be possible without the 4,000 Orionees who build well-being around the world. At Orion Pharma, op...
17/03/2026

None of our work would be possible without the 4,000 Orionees who build well-being around the world. At Orion Pharma, openness, trust, and collaboration are part of our DNA. When our people feel heard, supported, and inspired, they can do work that truly matters. 💎

In 2025, to further strengthen the well-being of our people, we have, for example:

✅ Increased annual short-term incentives globally by 5 million euros to support a high-performance culture and accelerate strategy ex*****on.

✅ Launched the Stellar recognition tool to highlight positive contributions, celebrate everyday successes, and reinforce our shared values. In just three months in 2025, Orionees sent nearly 900 recognition cards to one another!

Discover more People highlights: https://www.orionpharma.com/investors/highlights-2025/

Osoite

Orionintie 1 A
Espoo
02200

Puhelin

+358104261

Nettisivu

https://www.orionpharma.com/contact-us/product-related-questions-and-feedback/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Orion Pharma :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Ota Yhteyttä Vastaanotto

Lähetä viesti Orion Pharma :lle:

Jaa